🇺🇸 Locapred@ in United States

79 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 15 reports (18.99%)
  2. Cutaneous T-Cell Lymphoma — 12 reports (15.19%)
  3. Psoriasis — 11 reports (13.92%)
  4. Pruritus — 7 reports (8.86%)
  5. Rectal Haemorrhage — 7 reports (8.86%)
  6. Adenocarcinoma Of Colon — 6 reports (7.59%)
  7. Dermatitis Exfoliative Generalised — 6 reports (7.59%)
  8. Off Label Use — 5 reports (6.33%)
  9. Pyrexia — 5 reports (6.33%)
  10. Tooth Abscess — 5 reports (6.33%)

Source database →

Other Dermatology approved in United States

Frequently asked questions

Is Locapred@ approved in United States?

Locapred@ does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Locapred@ in United States?

Pierre Fabre Medicament is the originator. The local marketing authorisation holder may differ — check the official source linked above.